Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
66 Cards in this Set
- Front
- Back
OSMOSIS
|
A MOLOCULE MOVING ACROSS A MEMBRANE
|
|
PHARMOKENETICS
|
THE STUDY OF HOW A DRUG ENTERS, MOVES THROUGH, AND EXITS THE BODY
|
|
PHARMODYNAMICS
|
THE STUDY OF A DRUGS EFFECTS ON A BODY |
|
ASSAY
|
INVESTIGATIVE PROCEDURE FOR QUALITY ASSURANCE OFQUANITIVE MEASUREMENT, OR FUNCTIONAL ACTIVITY OF A DRUG |
|
BIOEQUIVALENCE
|
I.E. CIALIS , VIAGRA |
|
BIOASSAY
|
EXPERIMENT ON LIVE SUBJECT TO DETERMINE BIOLOGIC ACTIVITY OF A DRUG |
|
TERATOGENIC
|
AGENT (DRUG) THAT CAN CAUSE A BIRTH DEFECT |
|
THERAPEUDIC INDEX |
DRUGS DESIRED DOSE VS. DRUG TOXCICITY AMOUNT |
|
LETHAL DOSE |
DOSE, USUALY IN DOSE PER kg. THAT WILL BE FATAL |
|
EFFECTIVE DOSE |
DOSE THAT PRODUCES A THERAPEUDIC RESPONCE |
|
SECOND MESSENGER |
MOLOCULES THAT RELAY SIGNALS RECIEVED AT THE RECEPTORS ON THE CELL LEVEL |
|
DIFFUSION |
MOLOCULES INTERMINGLEING |
|
FILTRATION
|
SEPARATION OF SOLIDS FROM LIQUIDS |
|
BIOAVALIBILITY
|
I.E. I.V. FLUIDS WILL HAVE A BIOAVALIBILITY OF 100% |
|
BLOOD BRAIN BARRIER |
MEMBRANE SEPARATING BLOOD FROM BRAIN EXTRACELLULAR FLUID |
|
PLACENTAL BARRIER |
MEMBRANE SEPARATING MATERNAL BLOOD FROM FETAL BLOOD |
|
METABOLISIM |
ALL CHEMICAL REACTIONS INVOLVED IN MAINTAINING THE STATE OF A CELL AND THE ORGANISIM |
|
BIOTRANSFORMATION |
WHEN A SUBSTANCE IS CHANGED FROM ONE CHEMICLE TO ANOTHER BY A CHEMICAL REACTION |
|
FIRST PASS EFFECT |
PHENOMENON BY WHICH A DRUG IS GREATLY REDUCED BEFORE IT REACHES SYSTEMIC CIRCULATION |
|
RECEPTOR
|
ORGAN OR CELL ABLE TO RESPOND TO LIGHT HEAT OR OTHER EXTERNAL SOURCES AND TRANSMIT A SIGNAL |
|
AFFINITY |
ABILITY OF A DRUG TO BIND TO ITS BIOLOGICAL AGENT |
|
EFFICACY |
CAPACITY FOR THERAPEUDIC EFFECT OF A GIVEN INTERVENTION |
|
AGONIST
|
CHEMICAL THAT BINDS TO A RECEPTOR AND ACTIVATES IT TO PRODUCE A BIOLOGIC RESPONSE |
|
ANTAGONIST
|
CHEMICAL THAT BINDS TO A RECEPTOR AND CANNOT ACTIVATE IT |
|
AGONIST-ANTAGONIST |
HAS PROPERTIES OF BOTH AN AGONIST AND AN ANTAGONIST |
|
ONSET OF ACTION |
DURATION OF TIME FOR A DRUGS EFFECTS TO COME TO PROMONINCE UPON ADMINISTRATION |
|
DURATION OF ACTION |
LENGTH OF TIME A DRUG IS EFFECTIVE |
|
BIOLOGIC HALF-LIFE |
TIME IT TAKES A DRUG TO LOSE HALF OF ITS PHARMAOLOGIC ACTIVITY |
|
MEDICATION CONCENTRATION |
I.E. mg/ml |
|
ISOTONIC SOLUTIONS |
MOVEMENT OF WATER OUT OF A CELL IS BALANCED BY WATER MOVING IN I.E. ANIMALS CELLS ARE IN I.S. WITH .09% NaCl (NORMAL SALINE) |
|
PURE FOOD AND DRUG ACT 1906
|
IMPROVE QUALITY AND LABELING OF DRUGS NAMED UNITED STATES PHARMOCOPEA (USP) AS THE COUNTRIES OFFICIAL SOURCE FOR DRUG INFORMATION |
|
HARRISON NARCOTIC ACT 1914
|
LIMITED USE OF ADDICTING DRUGS BY REGULATING IMPORTATION MANUF. AND SALE AND USE OF OPIUM COCAINE AND THEIR COMPOUNDS |
|
FEDERAL FOOD DRUG AND COSMETIC ACT 1938 |
EMPOWERED FDA TO ENFORCE AND SET PREMARKET SAFETY STANDARDS FOR DRUGS
|
|
DURHAM-HUMPHERY AMENDMENTS
|
REQUIRES PHARMASISTS TO HAVE WRITTEN OR ORAL PRESCRIPTIONS FROM A PHYSICIAN TO DISPENCE CERTAIN DRUGS |
|
KEFAUVER HARRIS AMENDMENT 1962
|
REQUIRED MAUNFACTURERS TO PROVIDE PROOF SAFETY AND EFFECTIVENESS OF THEIR DRUGS BEFOR EBEING GRANTED PERMISSION TO PRODUCE AND MARKET PRODUCTS |
|
COMPREHENSIVE DRUG ABUSE AND PREVENTION ACT 1970
|
(CONTROLLED SUBSTANCE ACT) REPLACED HARRISON ACT AND CREATED 5 SCHEDULES OF CONTOLLED SUBSTANCES
|
|
DRUG SOURCES
|
DRUGS.COM WEBMD SKYSCAPE MEDIMATH USP |
|
DRUG SOURCES (4 TYPES) |
PLANT-MORPHINE, ATROPINE, ANIMAL- INSULIN, OXYTOCIN MINERAL- SODIUM BICARB, CALCIUM CHLORIDE SYNTHETIC- ADENOSINE, DIAZEPAM,HEP B VACC. |
|
DRUG STORAGE
|
KEEP DRUGHS IN A LOCKED SAFE OR BOX ON THE UNIT PER FEDERAL LAW, IF MEDS ARE IN A JUMP BAG MUST BE SEALED WITH TAMPER RESISTANT SEAL |
|
ETERAL DRUG ROUTE |
DRUGS ABSORBED BY G.I. TRACT
|
|
PARENTRAL
|
LIQUID MEDICATION GIVEN BY I.V. I.M. OR SUB Q. |
|
SIX RIGHTS TO MEDICATION ADMINISTRATION |
RIGHT MED RIGHT ROUTE RIGHT DOSE RIGHT TIME RIGHT DOCUMENTATION |
|
ORAL
|
30-45 MIN MOST CONVINIENT |
|
SUBLINGUIL
|
MUCOSSA UNDER TOUNGE VERY VASCULAR |
|
BUCCCAL
|
MUCOSSA BETWEEN CHEEK AND GUM |
|
SCHEDULE I DRUG
|
I.E. HEROIN, LSD |
|
SCHEDULE II DRUG
|
I.E. OPIUM, OXYCODINE, COCAINE, METHADONE, MORPHINE |
|
SCHEDULE III DRUG
|
I.E. VICODIN, TYLENOL WITH CODINE, LIMITED OPIOID AMOUNTS OR COMBINED WITH OTHER NON CONTROLLED SUBSTANCES |
|
DRUG FORMS
|
SOLIDS; POWDERS,TABLETS,SUPPOSITORIES LIQUIDS; SOLUTIONS,TINCTURES, INHALANTS |
|
SIMPLEST FORM OF B.S.I.
|
HANDWASHING |
|
PHASE I FDA APPROVAL
|
DETERMINE DRUGS PHARMOKINETICS, TOXCICITY, AND SAFE DOSE IN HUMANS |
|
PHASE II FDA APPROVAL |
TESTED ON A LIMITED POPULATION OF PTS WHO HAVE THE DISEASE INTENDED TO BE TREATED BY THE MEDICATION, FIND THERAPUDIC LEVEL AND WATCH FOR TOXIC EFFECTS |
|
PHASE III FDA APPROVAL |
I.E. DOUBLE BLIND STUDIES AND CONTROLLED STUDIES ABLE TO APPLY FOR NEW DRUG APPLICATION AFTER COMPLETION |
|
PHASE IV FDA APPROVAL
|
POSTMARKETING ANALYISIS DURING CONDITIONAL APPROVAL |
|
8 FACTORS ALTERING DRUG RESPONSE
|
AGE BODY MASS SEX ENVIROMENTAL MILIEU (MOOD AND ENVIROMENT) TIME OF ADMINISTRATION PATHOLOGICAL STATE GENETIC FACTORS PSYCHOLOGICAL FACTORS |
|
IDIOSYCRASY
|
DRUG EFFECT THAT IS UNIQUE TO THE INDIVIDUAL |
|
CROSS TOLLERANCE |
I.E. MORPHINE AND OPIOIDS |
|
ALLERGIC REACTION |
ALSO REFERED TO AS HYPERSENSITIVITY, ACTIVATES IMMUNE SYSTEM |
|
SYNERGISIM |
TWO DRUGS TAT HAVE THE SAME EFFECT THAT ARE GIVEN TOGETHER AND PRODUCE A RESPONCE GREATER THAN THE SUM OF THEIR INDIVIDUAL RESPONSES. 1+1=3 |
|
PASSIVE TRANSPORT
|
THE MOVEMENT OF A SUBSTANCE WITHOUT THE USE OF ENERGY |
|
FACILITATED TRANSPORT
|
THE MOVEMENT OF A SUBSTANCE WITH THE USE OF ENERGY |
|
NON COMPETITIVE ANTAGONISIM
|
OCCURS BECAUSE THE BINDING OF THE ANTAGONIST AT A DIFFERENT SITE CAUSES A DEFORMITY AND PREVENTS THE AGONIST FROM FITTING AND BINDING |
|
POTENTIATION |
ENHANCEMENT OF ONE AGENT BY ANOTHER SO THE COMBINED EFECT IS GREATER THAN THAT OF ONE AGENT ALONE |
|
ELIMINATION
|
PROCESS OF EXERTION OF AN AGENT BY ANY ONE NUMBER OF PROCESSES BY WHICH A DRUG IS ELIMINATED |
|
ADVERSE REACTION
|
ANY UNEXPECTED OR DANGEROUS REACTION TO A DRUG |
|
ABSORBTION |
IS THE PROCESS OF MOVEMENT OF A MEDICATION FROM THE SITE OF APPLICATION TO THE EXTRACELLULAR COMPARTMENT. |